These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33840204)

  • 1. High-Density Lipoprotein Anti-Inflammatory Capacity and Incident Cardiovascular Events.
    Jia C; Anderson JLC; Gruppen EG; Lei Y; Bakker SJL; Dullaart RPF; Tietge UJF
    Circulation; 2021 May; 143(20):1935-1945. PubMed ID: 33840204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).
    Khera AV; Demler OV; Adelman SJ; Collins HL; Glynn RJ; Ridker PM; Rader DJ; Mora S
    Circulation; 2017 Jun; 135(25):2494-2504. PubMed ID: 28450350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDL cholesterol efflux capacity and incident cardiovascular events.
    Rohatgi A; Khera A; Berry JD; Givens EG; Ayers CR; Wedin KE; Neeland IJ; Yuhanna IS; Rader DR; de Lemos JA; Shaul PW
    N Engl J Med; 2014 Dec; 371(25):2383-93. PubMed ID: 25404125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDL (High-Density Lipoprotein) Cholesterol Efflux Capacity Is Associated With Incident Cardiovascular Disease in the General Population.
    Ebtehaj S; Gruppen EG; Bakker SJL; Dullaart RPF; Tietge UJF
    Arterioscler Thromb Vasc Biol; 2019 Sep; 39(9):1874-1883. PubMed ID: 31315436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Inflammatory HDL Function, Incident Cardiovascular Events, and Mortality: A Secondary Analysis of the JUPITER Randomized Clinical Trial.
    Ajala ON; Demler OV; Liu Y; Farukhi Z; Adelman SJ; Collins HL; Ridker PM; Rader DJ; Glynn RJ; Mora S
    J Am Heart Assoc; 2020 Sep; 9(17):e016507. PubMed ID: 32799709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysfunctional High-Density Lipoproteins Are Associated With a Greater Incidence of Acute Coronary Syndrome in a Population at High Cardiovascular Risk: A Nested Case-Control Study.
    Soria-Florido MT; Castañer O; Lassale C; Estruch R; Salas-Salvadó J; Martínez-González MÁ; Corella D; Ros E; Arós F; Elosua R; Lapetra J; Fiol M; Alonso-Gómez A; Gómez-Gracia E; Serra-Majem L; Pintó X; Bulló M; Ruiz-Canela M; Sorlí JV; Hernáez Á; Fitó M
    Circulation; 2020 Feb; 141(6):444-453. PubMed ID: 31941372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the serum myeloperoxidase/high-density lipoprotein particle ratio and incident cardiovascular events in a multi-ethnic population: Observations from the Dallas Heart Study.
    Khine HW; Teiber JF; Haley RW; Khera A; Ayers CR; Rohatgi A
    Atherosclerosis; 2017 Aug; 263():156-162. PubMed ID: 28645072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDL function is impaired in acute myocardial infarction independent of plasma HDL cholesterol levels.
    Annema W; Willemsen HM; de Boer JF; Dikkers A; van der Giet M; Nieuwland W; Muller Kobold AC; van Pelt LJ; Slart RH; van der Horst IC; Dullaart RP; Tio RA; Tietge UJ
    J Clin Lipidol; 2016; 10(6):1318-1328. PubMed ID: 27919348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol Mass Efflux Capacity, Incident Cardiovascular Disease, and Progression of Carotid Plaque.
    Shea S; Stein JH; Jorgensen NW; McClelland RL; Tascau L; Shrager S; Heinecke JW; Yvan-Charvet L; Tall AR
    Arterioscler Thromb Vasc Biol; 2019 Jan; 39(1):89-96. PubMed ID: 30580560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study.
    Saleheen D; Scott R; Javad S; Zhao W; Rodrigues A; Picataggi A; Lukmanova D; Mucksavage ML; Luben R; Billheimer J; Kastelein JJ; Boekholdt SM; Khaw KT; Wareham N; Rader DJ
    Lancet Diabetes Endocrinol; 2015 Jul; 3(7):507-13. PubMed ID: 26025389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-free, high-density lipoprotein-specific phospholipid efflux assay predicts incident cardiovascular disease.
    Sato M; Neufeld EB; Playford MP; Lei Y; Sorokin AV; Aponte AM; Freeman LA; Gordon SM; Dey AK; Jeiran K; Hamasaki M; Sampson ML; Shamburek RD; Tang J; Chen MY; Kotani K; Anderson JL; Dullaart RP; Mehta NN; Tietge UJ; Remaley AT
    J Clin Invest; 2023 Sep; 133(18):. PubMed ID: 37471145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-inflammatory function of HDL is impaired in type 2 diabetes: role of hyperglycemia, paraoxonase-1 and low grade inflammation.
    Ebtehaj S; Gruppen EG; Parvizi M; Tietge UJF; Dullaart RPF
    Cardiovasc Diabetol; 2017 Oct; 16(1):132. PubMed ID: 29025405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Size-Based High-Density Lipoprotein Subspecies and Incident Vascular Events.
    Deets A; Joshi PH; Chandra A; Singh K; Khera A; Virani SS; Ballantyne CM; Otvos JD; Dullaart RPF; Gruppen EG; Connelly MA; Ayers C; Navar AM; Pandey A; Wilkins JT; Rohatgi A
    J Am Heart Assoc; 2023 Nov; 12(21):e031160. PubMed ID: 37929707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Density Lipoprotein Subclasses and Noncardiovascular, Noncancer Chronic Inflammatory-Related Events Versus Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis.
    Duprez DA; Otvos J; Tracy RP; Feingold KR; Greenland P; Gross MD; Lima JA; Mackey RH; Neaton JD; Sanchez OA; Jacobs DR
    J Am Heart Assoc; 2015 Sep; 4(9):e002295. PubMed ID: 26370448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HDL anti-inflammatory function is impaired in myocardial infarction and may predict new cardiac events independent of HDL cholesterol.
    Dullaart RP; Annema W; Tio RA; Tietge UJ
    Clin Chim Acta; 2014 Jun; 433():34-8. PubMed ID: 24613518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal HDL Cholesterol Efflux and Anti-Inflammatory Capacities in Type 2 Diabetes Despite Lipidomic Abnormalities.
    Denimal D; Benanaya S; Monier S; Simoneau I; Pais de Barros JP; Le Goff W; Bouillet B; Vergès B; Duvillard L
    J Clin Endocrinol Metab; 2022 Aug; 107(9):e3816-e3823. PubMed ID: 35647758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The high-density lipoprotein cholesterol (HDL-C)-concentration-dependent association between anti-inflammatory capacity and sepsis: A single-center cross-sectional study.
    Chen KL; Chou RH; Chang CC; Kuo CS; Wei JH; Huang PH; Lin SJ
    PLoS One; 2024; 19(4):e0296863. PubMed ID: 38603717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cholesteryl ester transfer protein by anacetrapib does not impair the anti-inflammatory properties of high density lipoprotein.
    Han S; Levoci L; Fischer P; Wang SP; Gagen K; Chen Y; Xie D; Fisher T; Ehrhardt AG; Peier AM; Johns DG
    Biochim Biophys Acta; 2013 Apr; 1831(4):825-33. PubMed ID: 23269286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired HDL Metabolism Links GlycA, A Novel Inflammatory Marker, with Incident Cardiovascular Events.
    Riggs KA; Joshi PH; Khera A; Singh K; Akinmolayemi O; Ayers CR; Rohatgi A
    J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31817053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.
    Khera AV; Cuchel M; de la Llera-Moya M; Rodrigues A; Burke MF; Jafri K; French BC; Phillips JA; Mucksavage ML; Wilensky RL; Mohler ER; Rothblat GH; Rader DJ
    N Engl J Med; 2011 Jan; 364(2):127-35. PubMed ID: 21226578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.